Monofunctional Platinum-DNA Adducts Are Strong Inhibitors of Transcription and Substrates for Nucleotide Excision Repair in Live Mammalian Cells
To overcome drug resistance and reduce the side effects of cisplatin, a widely used antineoplastic agent, major efforts have been made to develop next generation platinum-based anticancer drugs. Because cisplatin-DNA adducts block RNA polymerase II unless removed by transcription-coupled excision re...
Main Authors: | Zhu, Guangyu (Contributor), Myint, MyatNoeZin (Contributor), Ang, Wee Han (Contributor), Song, Lina (Contributor), Lippard, Stephen J. (Contributor) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Massachusetts Institute of Technology. Department of Chemistry (Contributor) |
Format: | Article |
Language: | English |
Published: |
American Association for Cancer Research,
2012-08-02T18:54:21Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Transcription Inhibition by Platinum DNA Cross-links in Live Mammalian Cells
by: Ang, Wee Han, et al.
Published: (2011) -
Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
by: Graf, Nora, et al.
Published: (2012) -
X-ray structure and mechanism of RNA polymerase II stalled at an antineoplastic monofunctional platinum-DNA adduct
by: Zhu, Guangyu, et al.
Published: (2013) -
Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin
by: Riddell, Imogen Anne, et al.
Published: (2016) -
Monofunctional and Higher-Valent Platinum Anticancer Agents
by: Wilson, Justin J., et al.
Published: (2015)